criteria for the diagnosis of accelerated/blast phase mpn and challenges clinicians may face
Published 2 months ago • 153 plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation
-
1:26
current and emerging prognostic factors for mds/mpn
-
3:10
the role of ngs in mds diagnosis
-
3:01
challenges in distinguishing between pre-mds states and mds, and approaches to improve diagnosis
-
11:33
treatment algorithm for low-risk mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
4:00
mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension
-
24:41
the operational model explained part 1
-
50:56
chip and ccus, precursors to mds
-
1:05
the future of managing precursor conditions
-
3:08
the treatment protocol for higher risk mds
-
1:38
an overview of the practical challenges in approaching r/r amyloidosis
-
3:57
validation of the ipss-m risk stratification system in mds
-
2:15
improving the specificity of molecular mrd detection
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
0:47
overview of the phase iii enhance trial schema
-
2:16
current and future treatment approaches for hr-mds
-
3:47
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
1:30
the prognostic value of patient-reported outcomes in mds